U.S. Food and Drug Administration

Featured

Lung Illnesses Associated with Use of Vaping Products

Information for the Public, FDA Actions, and Recommendations

Food

Drugs

Medical Devices

Radiation-Emitting Products

Vaccines, Blood, and Biologics

Animal and Veterinary

Cosmetics

Tobacco Products

composite image showing concept of FDA research and technology

FDA’s Technology Modernization Action Plan

The plan describes important near-term actions that FDA is taking to modernize use of technology—computer hardware, software, data, and analytics—to advance FDA’s public health mission.

Science-related icons juxtoposed on a background of prescription paperwork

Fostering Drug Competition

Increasing the availability of generic drugs helps to create competition in the marketplace, helping make treatment more affordable and increasing access to healthcare for more patients.

Closeup shot of a nurse holding a patient's hand in comfort in a hospital

Combating the Opioid Crisis

FDA takes actions to combat prescription opioid abuse.

Sep 20

Statement on continued efforts to increase availability of all forms of naloxone to help reduce opioid overdose deaths

Sep 20

FDA issues proposed rule for premarket tobacco product applications as part of commitment to continuing strong oversight of e-cigarettes and other tobacco products

More Press Announcements

Newsroom Meetings Testimony Speeches

Sep 20

Roland Foods, LLC Initiates a Voluntary Recall of Roland Red Lumpfish Caviar and Roland Black Lumpfish Caviar Due to Possible Health Risk

Food & Beverages

Sep 19

Ridley Block Operations Voluntarily Recalls a Batch of Ultralyx 2416-5 No Other Products are Affected; Distribution was Limited to Georgia and Florida

Animal & Veterinary

Sep 19

Updated: Torrent Pharmaceuticals Limited Expands Voluntary Nationwide Recall of Losartan Potassium Tablets, USP and Losartan Potassium / Hydrochlorothiazide Tablets, USP

Drugs

FDA’s Comprehensive Response to HIV — Part II

FDA plays a pivotal role in advancing HIV therapies in underserved global markets through the President’s Emergency Plan for AIDS Relief (PEPFAR).

young male patient conversing with doctor in examining room while looking at iPad

FDA’s Comprehensive Response to HIV — Part I

A multidisciplinary approach helps spur the development of effective treatments and approval of an expanding number of HIV drugs and drug combinations.

collage of three photos featuring: a hopeful young adult cancer patient embraced by supportive mother, young male scientist looking into a microscope, and a medical professional reviewing data on an iPad

Delivering Promising New Medicines Without Sacrificing Safety and Efficacy

All drugs approved under the agency’s expedited programs are held to the same approval standards as other FDA drug approvals.

Sep 23